Shiseido
Replicel Terminates License With Shiseido: Update (12/21/21) Two months after Replicel announced that it was entering arbitration proceedings with Shiseido, the company has announced today that it has terminated its license agreement with Shiseido. The license agreement between Replicel and Shiseido dates back to 2013 when Shiseido paid an upfront fee to gain the rights…
Read MoreIn this article we will take a look at the most promising developments slated to occur in the hair restoration industry in 2020. Clinical Treatments And Drugs For Hair Loss In 2020 TissUse & J Hewitt – TissUse’s hair regeneration therapy is known as the Smart Hair Transplant or SHT which has been in development…
Read MoreAs we get further into the year of 2019 the majority of the online crowd is intently watching for an update from the pivotal RCH-01 trial being sponsored by Shiseido in Japan. Three Years In Japan To recap, back in July 2016, Replicel and Shiseido made headlines by announcing that Shiseido’s trial of the RCH-01…
Read MoreIt appears that the Shiseido trial results for Replicel’s RCH-01 will finally be revealed sometime around July 2019. In my post on WCHR 2019 Highlights a commenter named Neez shared this message: “Someone working on the rch-01 trial send this mail to a guy asking about the phase II results: Dear *****, The results will…
Read MoreReplicel has shared a newsletter today, March 5, 2019, addressing several facets of the company’s progress and product development. The big question for many people lately has been an update on RCH-01/Shiseido, this topic is briefly addressed in the newsletter. Replicel states that “With the clinical study of RCH-01 now successfully completed in Japan, RepliCel…
Read More
After I shared an update about a potential announcement time frame for Shiseido a few weeks ago, I read a few queries from readers who wondered if a Shiseido market release would be available to everyone in the world. Today, I received more positive news from a credible source to help clear things up. Once again,…
Read More
Follicle Thought has received a brief update to share regarding the progress of the highly anticipated company Shiseido. On July 4th I sent a tweet to Replicel CEO Lee Buckler asking him when he thought we would hear an announcement from Shiseido pertaining to their trial of RCH-01. His response is shown below. As you…
Read More
As one of the top two hair growth treatments projected to reach the market in 2018, Replicel’s RCH-01 has a lot of people’s attention these days. When it was announced that the global cosmetic company Shiseido would trial Replicel’s hair growth technology in Japan, there was also talk from Shiseido that the treatment could reach…
Read MoreA Happy New Year to all of you from Follicle Thought. I’ve always enjoyed doing the year ahead preview posts and this one is no exception. A new year does bring us new opportunities and should be a reason for renewed hope. This is also the first year since I’ve started Follicle Thought that a…
Read More
I’ve got a good feeling about 2017… For the past several years we have been pacified by the news of a research study or startup company working on a treatment that grows hair. Ultimately, we would prefer the treatment in our hands, but reading about it on a computer screen has been supportive as well.…
Read More